scispace - formally typeset
O

Olivier Blanc-Brude

Researcher at French Institute of Health and Medical Research

Publications -  51
Citations -  3665

Olivier Blanc-Brude is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Angiogenesis & Apoptosis. The author has an hindex of 25, co-authored 49 publications receiving 3241 citations. Previous affiliations of Olivier Blanc-Brude include University College London & Paris Descartes University.

Papers
More filters
Journal ArticleDOI

Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis

TL;DR: This work is the first demonstration of the therapeutic potential of MSCs-derived EVs in inflammatory arthritis and exerts an anti-inflammatory role on T and B lymphocytes independently of M SCs priming.
Journal ArticleDOI

Lactadherin promotes VEGF-dependent neovascularization

TL;DR: It is shown that an integrin-binding protein initially described in milk-fat globule, MFG-E8 (also known as lactadherin), is expressed in and around blood vessels and has a crucial role in VEGF-dependent neovascularization in the adult mouse.
Journal ArticleDOI

Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice.

TL;DR: Lack of Mfge8 in bone marrow–derived cells enhances the accumulation of apoptotic cell corpses in atherosclerosis and alters the protective immune response, which leads to an acceleration of plaque development.
Journal ArticleDOI

Thrombin Is a Potent Inducer of Connective Tissue Growth Factor Production via Proteolytic Activation of Protease-activated Receptor-1

TL;DR: It is proposed that coagulation proteases and PAR-1 may play a role in promoting connective tissue formation during normal tissue repair and the development of fibrosis by up-regulating fibroblast CTGF expression.
Journal Article

Therapeutic Targeting of the Survivin Pathway in Cancer Initiation of Mitochondrial Apoptosis and Suppression of Tumor-associated Angiogenesis

TL;DR: Survivin functions as a novel upstream regulator of mitochondrial-dependent apoptosis, and molecular targeting of this pathway results in anticancer activity via a dual mechanism of induction of tumor cell apoptosis and suppression of angiogenesis.